Y Kishimoto, H Oga - US Patent 20,110,142,983, 2011 - freepatentsonline.com 1. A method for inhibiting a postprandial increase in blood neutral fats, comprising ingesting a water-soluble and hardly digestible starch decomposed product containing hardly digestible components in an amount of at least 35% by mass as a solid content, wherein said ... Cached
TE McIff, AM Poisner, B Herndon… - The Journal of …, 2011 - journals.lww.com ... Methods: A model of FE in unanesthetized rats, using intravenous injection of the neutralfat triolein, was used to study the potential therapeutic effect on lung histopathology of altering the production of, or response to, endogenous angiotensin (Ang) II. ... Related articles - All 5 versions
[HTML] from nih.govFPW Radner, S Grond, G Haemmerle… - Dermato- …, 2011 - ncbi.nlm.nih.gov Keratinocyte differentiation is essential for skin development and the formation of the skin permeability barrier. This process involves an orchestrated remodeling of lipids. The cleavage of precursor lipids from lamellar bodies by β-glucocerebrosidase, sphingomyelinase, phospholipases ... Related articles - All 6 versions
GV Subbarao, K Nakahara, T Ishikawa, O Ito… - US Patent …, 2011 - Google Patents ... to the above-mentioned constitution, a nitrification inhibitor to prevent nitrification of soil can be offered by using either one of linoleic acid, a-li- nolenic acid, y-linolenic acid, and methyl linoleate which can be easily manufactured by decomposing a neutralfat con- tained in ... Related articles - All 4 versions
[HTML] from nih.govL Van Oudenhove, S McKie, D Lassman… - The Journal of clinical …, 2011 - ncbi.nlm.nih.gov ... For each participant, the signal averages for the 15 postinfusion time bins (T1–T15) were compared with the baseline average (T0) under each condition (fatneutral [FN], vehicle neutral [VN], fat sad [FS], and vehicle sad [VS]), resulting in 15 first-level β images per condition ... Cited by 2
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
